Mobile

A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metfo...

Update Il y a 4 ans
Reference: EUCTR2006-001392-37

A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Main objective : After 18 weeks, to assess the effect of the addition of treatment with sitagliptin compared to placebo on HbAıc.

Inclusion criteria

  • Type 2 diabetes mellitus

Links